Which closed-end funds own Kailera Therapeutics Inc?
7 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $5.4M. Security type: common equity. Country: United States. CUSIP 482931102 · ISIN US4829311020 · ticker KLRA.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust | Healthcare | 0.16% | $906K | 41,127 sh | $573M | 3.7% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.11% | $1.2M | 52,563 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.10% | $220K | 10,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.09% | $897K | 40,727 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 0.08% | $561K | 25,455 sh | $689M | 4.3% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.08% | $1.1M | 49,509 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.08% | $536K | 24,309 sh | $690M | 3.5% discount | Jun 30, 2026 |
7 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: KAILERA THERAPEUTICS INC.
Issuer-level search for “KLRA” → · Compare two funds’ portfolios →